Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical benzoyl peroxide for prolonged EGFR inhibitor–induced acneiform eruption
jRCTs021180037Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of benzoyl peroxide in acneiform disorders and cutaneous reaction, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Severity grade of acneiform eruption on the face. Started Aug 2018; status: completed.
02
Drugs
benzoyl peroxide
03
Conditions
acneiform disorderscutaneous reaction
Beyond the preview
Go deeper on jRCTs021180037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180037.